Gabriel Leung - Net Worth and Insider Trading
Gabriel Leung Net Worth
The estimated net worth of Gabriel Leung is at least $2 Million dollars as of 2025-04-12. Gabriel Leung is the Director of NovoCure Ltd and owns about 83,192 shares of NovoCure Ltd (NVCR) stock worth over $1 Million. Gabriel Leung is also the Director of Albany Molecular Research Inc and owns about 13,254 shares of Albany Molecular Research Inc (AMRI) stock worth over $288,142. Details can be seen in Gabriel Leung's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Gabriel Leung has not made any transactions after 2024-06-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Gabriel Leung
Gabriel Leung Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Gabriel Leung owns 4 companies in total, including NovoCure Ltd (NVCR) , Pernix Therapeutics Holdings Inc (PTXTQ) , and Albany Molecular Research Inc (AMRI) among others .
Click here to see the complete history of Gabriel Leung’s form 4 insider trades.
Insider Ownership Summary of Gabriel Leung
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NVCR | NovoCure Ltd | 2024-06-04 | director |
| PTXTQ | Pernix Therapeutics Holdings Inc | 2018-05-22 | director |
| AMRI | Albany Molecular Research Inc | 2015-03-02 | director |
 | | 2011-03-30 | director |
Gabriel Leung Latest Holdings Summary
Gabriel Leung currently owns a total of 2 stocks. Among these stocks, Gabriel Leung owns 83,192 shares of NovoCure Ltd (NVCR) as of June 4, 2024, with a value of $1 Million and a weighting of 82.65%. Gabriel Leung also owns 13,254 shares of Albany Molecular Research Inc (AMRI) as of December 7, 2011, with a value of $288,142 and a weighting of 17.35%.
Latest Holdings of Gabriel Leung
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NVCR | NovoCure Ltd | 2024-06-04 | 83,192 | 16.50 | 1,372,668 |
| AMRI | Albany Molecular Research Inc | 2011-12-07 | 13,254 | 21.74 | 288,142 |
Holding Weightings of Gabriel Leung
Gabriel Leung Form 4 Trading Tracker
According to the SEC Form 4 filings, Gabriel Leung has made a total of 12 transactions in NovoCure Ltd (NVCR) over the past 5 years, including 0 buys and 12 sells. The most-recent trade in NovoCure Ltd is the sale of 964 shares on June 4, 2024, which brought Gabriel Leung around $23,030.
According to the SEC Form 4 filings, Gabriel Leung has made a total of 0 transactions in Albany Molecular Research Inc (AMRI) over the past 5 years. The most-recent trade in Albany Molecular Research Inc is the acquisition of 8,000 shares on December 7, 2011, which cost Gabriel Leung around $19,200.
Insider Trading History of Gabriel Leung
- 1
Gabriel Leung Trading Performance
GuruFocus tracks the stock performance after each of Gabriel Leung's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Gabriel Leung is 15.25%. GuruFocus also compares Gabriel Leung's trading performance to market benchmark return within the same time period. The performance of stocks bought by Gabriel Leung within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Gabriel Leung's insider trading performs compared to the benchmark.
Performance of Gabriel Leung
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 22.03 | | | | | |
| Relative Return to S&P 500(%) | 20.7 | | | | | |
Gabriel Leung Ownership Network
Ownership Network List of Gabriel Leung
Ownership Network Relation of Gabriel Leung
Gabriel Leung Owned Company Details
What does NovoCure Ltd do?
Who are the key executives at NovoCure Ltd?
Gabriel Leung is the director of NovoCure Ltd. Other key executives at NovoCure Ltd include Chief Financial Officer Ashley Cordova , President & CNS Cancers US Frank X Leonard , and Chief Innovation Officer Uri Weinberg .
NovoCure Ltd (NVCR) Insider Trades Summary
Over the past 18 months, Gabriel Leung made 1 insider transaction in NovoCure Ltd (NVCR) with a net sale of 964. Other recent insider transactions involving NovoCure Ltd (NVCR) include a net sale of 37,794 shares made by Frank X Leonard , a net sale of 1,982 shares made by , and a net sale of 29,729 shares made by Ashley Cordova .
In summary, during the past 3 months, insiders sold 79,948 shares of NovoCure Ltd (NVCR) in total and bought 0 shares, with a net sale of 79,948 shares. During the past 18 months, 97,906 shares of NovoCure Ltd (NVCR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 97,906 shares.
NovoCure Ltd (NVCR)'s detailed insider trading history can be found in Insider Trading Tracker table.
NovoCure Ltd Insider Transactions
Gabriel Leung Mailing Address
Above is the net worth, insider trading, and ownership report for Gabriel Leung. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Gabriel Leung's mailing address is: Morristown Nj 07960.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
